UNCY: Unicycive Therapeutics Investors with Losses Should Contact Block & Leviton About Securities Fraud Investigation

Block & Leviton is investigating Unicycive Therapeutics for potential securities law violations related to false or misleading statements about FDA review of its OLC New Drug Application. The company received a second Complete Response Letter on June 30, 2026, citing manufacturing deficiencies, which led to a stock price decline. Investors who have suffered losses are encouraged to contact the firm.

07/13/2026, 2:05 PM • GlobeNewswire

ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation

Hagens Berman is investigating Alignment Healthcare (ALHC) following whistleblower allegations that the company engaged in accounting irregularities, misclassifying operating expenses as capital expenditures to inflate EBITDA and financial metrics. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

07/08/2026, 9:20 PM • GlobeNewswire

ALHC ALERT: Block & Leviton Investigating Alignment Healthcare, Inc. For Possible Securities Fraud; Investors Should Contact Block & Leviton to Learn More

Block & Leviton is investigating Alignment Healthcare, Inc. (ALHC) for potential securities law violations following allegations that a former executive filed a whistleblower lawsuit claiming the company manipulated finances to boost stock price and executive compensation. The stock fell approximately 16.72% following the report. The firm is also investigating Jefferies Financial Group and Unicycive Therapeutics for similar violations.

07/08/2026, 5:47 PM • GlobeNewswire

ALHC Investor Notice: Johnson Fistel Investigates Alignment Healthcare, Inc.

Law firm Johnson Fistel announced an investigation into Alignment Healthcare (NASDAQ: ALHC) following a whistleblower lawsuit filed by a former executive alleging the company manipulated its finances to boost stock price and executive compensation. The firm is investigating whether the company complied with federal securities laws and is seeking investors who suffered losses.

07/08/2026, 3:42 PM • GlobeNewswire

Vice Chairman of Alignment Healthcare Sells 25,000 Shares. Does This Mean Sell ALHC?

Joseph Konowiecki, vice chairman of Alignment Healthcare, sold 25,000 shares on June 26 for $575,000, reducing his direct holdings by 2.2%. While the sale aligns with his historical trading pattern and occurs under a pre-filed trading plan, the timing coincides with his recent step down from chairman and follows a pattern of executive selling over the past year. However, insider sales are predictive of stock declines less than half the time, and investors should weigh this against other company fundamentals.

06/30/2026, 4:21 PM • The Motley Fool

Alignment Healthcare Stock Watch: Why This $550,000 Insider Sale Shouldn't Spook Investors

Alignment Healthcare's EVP Joseph Konowiecki sold 25,000 shares worth $550,000 under a pre-arranged trading plan, representing just 2.1% of his holdings. The article argues this routine sale shouldn't concern investors, as the company is executing well in the Medicare Advantage market with strong Q1 results showing 33.3% revenue growth, 30.9% membership growth, and a swing to profitability with management raising full-year guidance.

06/23/2026, 7:03 PM • The Motley Fool

Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report

Alignment Healthcare released its 2025 Impact Report demonstrating significant reductions in high-cost healthcare utilization among its Medicare Advantage members, including 34% fewer emergency room visits and inpatient admissions, and 44% fewer skilled nursing facility admissions compared to 2019 Medicare fee-for-service benchmarks. The company attributes these outcomes to its proactive care model featuring AI-powered technology (AVA) and in-home/virtual care programs, while maintaining 100% of members in 4-Star or higher rated plans.

06/02/2026, 8:00 AM • GlobeNewswire

Alignment Healthcare Set to Join S&P SmallCap 600

Alignment Healthcare Inc. (ALHC) will be added to the S&P SmallCap 600 index effective May 14, 2026, replacing Sun Country Airlines Holdings (SNCY). The replacement follows Allegiant Travel Co.'s acquisition of Sun Country Airlines, which is expected to close soon.

05/11/2026, 6:21 PM • Benzinga

UnitedHealth, Humana, CVS Jump As CMS Boosts Medicare Payments

The Centers for Medicare & Medicaid Services announced a 2.48% increase in 2027 Medicare Advantage capitation rates, exceeding initial expectations of 0.09%. The boost amounts to over $13 billion in additional payments and reflects a 4.98% increase when accounting for risk score trends. CMS retained the 2024 risk adjustment model, providing greater rate predictability for insurers. Major healthcare stocks surged on the positive announcement.

04/07/2026, 10:30 AM • Benzinga

Alignment Healthcare Announces Pricing of Secondary Offering

Alignment Healthcare (NASDAQ: ALHC) announced a secondary public offering of 13.2 million shares priced at $19.46 per share by an affiliate of General Atlantic. The company will not receive proceeds from the sale. The offering is expected to close on March 4, 2026, with J.P. Morgan serving as underwriter.

03/02/2026, 9:05 PM • GlobeNewswire

Medicare Shock Sends UnitedHealth, Humana And CVS Tumbling

The Centers for Medicare & Medicaid Services (CMS) proposed a 2027 Medicare Advantage payment increase of only 0.09%, significantly below Wall Street's expectations of 4-6%. This modest growth announcement triggered sharp declines in major health insurer stocks, with UnitedHealth, Humana, and CVS Health leading the losses. The CMS emphasized program sustainability and payment accuracy through updated risk adjustment models.

01/27/2026, 7:17 AM • Benzinga

Alignment Healthcare Named to the 2026 Fortune World’s Most Admired Companies™ List for First Time

Alignment Healthcare, a Medicare Advantage company, has been named to Fortune's 2026 World's Most Admired Companies list in its first year of consideration. The recognition reflects the company's leadership, innovation, and operating ability in the healthcare insurance sector. Alignment achieved this distinction alongside numerous 2025 accolades, including 100% of its members enrolled in 4-star or higher rated plans and recognition as one of Newsweek's World's Most Trustworthy Companies for the third consecutive year.

01/21/2026, 11:00 AM • GlobeNewswire

10% Owner Sells 11 Million Shares of Alignment Healthcare Shares for $206.5 Million After 74% Run

General Atlantic, a 10% owner of Alignment Healthcare, sold 11.1 million shares for $206.5 million on December 12, 2025, representing a 45.2% reduction in its stake. The sale occurred at $18.57 per share, slightly below the market close of $19.36, following a 74% stock price increase over the prior year. While Alignment Healthcare reported strong Q3 2025 results with 43.5% revenue growth and 31% membership growth, the insider selling and projected Medicare Advantage enrollment decline in 2026 warrant investor caution.

01/12/2026, 4:13 PM • The Motley Fool

Cigna Offers Cleaner Growth Than Other Health Insurers, Says Analyst

BofA Securities highlighted Cigna's strong potential in commercial health insurance, noting its pharmacy benefit management platform and ability to deliver 10-15% annual EPS growth, while also discussing challenges and opportunities in the healthcare insurance market.

12/17/2025, 1:55 PM • Benzinga

Alignment Healthcare to Present at Piper Sandler 37th Annual Healthcare Conference

Alignment Healthcare reported strong Q3 2025 financial performance, with revenue of $993.7 million, representing a 43.5% year-over-year increase. The company exceeded its high-end guidance and raised its full-year outlook across key metrics.

11/19/2025, 8:00 AM • GlobeNewswire